Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, we would like to inform you that the Rising Pharma Holdings, Inc. USA, a marketing and distribution partner of bliss GVS Pharma Limited (\the Company\) has been granted final approval from the U.S. Food & Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) for its product \Mesalamine Suppositories 1000 mg\. The ANDA was submitted through our partner in the USA.